首页 › 基金 › SB INVESTMENT ADVISERS (UK) LTD › RLAY
SB INVESTMENT ADVISERS (UK) LTD 对 RLAY 的持仓历史
RELAY THERAPEUTICS INC · 医疗保健
SB INVESTMENT ADVISERS (UK) LTD 在 Q3 2026 的 13F 申报中披露持有 RLAY(RELAY THERAPEUTICS INC)21,904,963 股,市值约 US$395.4M,约占其申报组合的 6.42%,在其申报持仓中市值排名第 3 位。 SB INVESTMENT ADVISERS (UK) LTD 最近 13 个申报季度中有 13 个季度披露了 RLAY 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
SB INVESTMENT ADVISERS (UK) LTD 对 RLAY 的持仓演变
SB INVESTMENT ADVISERS (UK) LTD 于 Q3 2023 首次披露 RLAY 持仓:27,904,963 股(约 US$234.7M)。 该持仓在 Q2 2026 达到峰值 27,904,963 股,市值约 US$522.1M。 在 13 次申报中,SB INVESTMENT ADVISERS (UK) LTD 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 21,904,963 股、市值约 US$395.4M,环比减持 -6,000,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 27.90M | $234.68M | 新进 |
| Q4 2023 | 27.90M | $307.23M | 持有 |
| Q1 2024 | 27.90M | $231.61M | 持有 |
| Q2 2024 | 27.90M | $181.94M | 持有 |
| Q3 2024 | 27.90M | $197.57M | 持有 |
| Q4 2024 | 27.90M | $114.97M | 持有 |
| Q1 2025 | 27.90M | $73.11M | 持有 |
| Q2 2025 | 27.90M | $96.55M | 持有 |
| Q3 2025 | 27.90M | $145.66M | 持有 |
| Q4 2025 | 27.90M | $236.08M | 持有 |
| Q1 2026 | 27.90M | $277.65M | 持有 |
| Q2 2026 | 27.90M | $522.10M | 持有 |
| Q3 2026 | 21.90M | $395.38M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RLAY 与 13F 数据
RLAY(RELAY THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 55 只申报持有 RLAY,申报仓位最大的包括:Casdin 资本 (US$289.4M), PERCEPTIVE ADVISORS LLC (US$229.8M), Commodore Capital LP (US$216.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RLAY 的基金
- Casdin 资本 16.04M 股 · $289.44M · Q3 2026
- PERCEPTIVE ADVISORS LLC 12.73M 股 · $229.78M · Q3 2026
- Commodore Capital LP 12.00M 股 · $216.60M · Q3 2026
- Nextech Invest Ltd. 6.78M 股 · $122.32M · Q3 2026
- Bellevue Group AG 6.19M 股 · $111.66M · Q3 2026
- TCG Crossover Management, LLC 3.78M 股 · $68.29M · Q3 2026
- Siren, L.L.C. 3.26M 股 · $58.90M · Q3 2026
- Spruce Street Capital LP 2.98M 股 · $53.86M · Q3 2026
- BAKER BROS. ADVISORS LP 2.83M 股 · $51.02M · Q3 2026
- Kynam Capital Management, LP 2.75M 股 · $49.66M · Q3 2026
- MPM BioImpact LLC 2.37M 股 · $42.77M · Q3 2026
- Elmind Capital, LP 1.47M 股 · $26.45M · Q3 2026
更多关于 SB INVESTMENT ADVISERS (UK) LTD
常见问题
How long has SB INVESTMENT ADVISERS (UK) LTD held RLAY?
SB INVESTMENT ADVISERS (UK) LTD has disclosed RLAY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SB INVESTMENT ADVISERS (UK) LTD's current position in RLAY?
As of Q3 2026, SB INVESTMENT ADVISERS (UK) LTD holds 21.90M shares of RLAY (RELAY THERAPEUTICS INC), valued at $395.38M, representing 6.42% of its reported portfolio and ranking #3.
Has SB INVESTMENT ADVISERS (UK) LTD been buying or selling RLAY?
In the latest 13F filing (Q3 2026), SB INVESTMENT ADVISERS (UK) LTD reduced its position in RLAY. The position peaked in Q2 2026 at 27.90M shares.
Which other funds hold RLAY?
Other major institutional holders of RLAY include Casdin 资本, PERCEPTIVE ADVISORS LLC, Commodore Capital LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.